Mutations in Niemann Pick type C gene are risk factor for Alzheimer's disease

Medical Hypotheses

Volumn 83, Issue 5, 2014, Pages 559-562

  Kresojević, Nikola ^a   Dobričić, Valerija ^a   Svetel, Marina ^a   Kostić, Vladimir ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE; CARRIER PROTEIN; GLYCOPROTEIN; MEMBRANE PROTEIN; NPC1 PROTEIN, HUMAN; NPC2 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; GENE; GENE MUTATION; GENETIC RISK; HETEROZYGOTE; HUMAN; HYPOTHESIS; LYSOSOME STORAGE DISEASE; NIEMANN PICK DISEASE; NIEMANN PICK TYPE C 1 GENE; NIEMANN PICK TYPE C 2 GENE; RISK FACTOR; SYNUCLEINOPATHY; TAUOPATHY; AGED; ANIMAL; DEMENTIA; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; MOUSE; MUTATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; CARRIER PROTEINS; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSYLCERAMIDASE; GLYCOPROTEINS; HETEROZYGOTE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MIDDLE AGED; MUTATION; NIEMANN-PICK DISEASE, TYPE C; RISK FACTORS;

EID: 84908233895     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.08.025     Document Type: Article

References (48)

1. Jellinger K.A. Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 2010, 14(3):457-487.
2. Mata I.F., Samii A., Schneer S.H., et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 2010, 65(3):379-382.
3. Anheim M., Elbaz A., Lesage S., et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 2012, 78(6):417-420.
4. Galvin J.E., Lee V.M., Trojanowski J.Q. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001, 58(2):186-190.
5. Puschmann A., Bhidayasiri R., Weiner W.J. Synucleinopathies from bench to bedside. Parkinsonism Relat Disord 2012, 18(Suppl. 1):S24-S27.
6. Iqbal K., Liu F., Gong C.X., Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 2010, 7(8):656-664.
7. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N Engl J Med 2010, 362:329-344.
8. Ludolph A.C., Kassubek J., Landwehrmeyer B.G., et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol 2009, 16(3):297-309.
9. Sidransky E. Gaucher disease: complexity in a "simple" disorder. Mol Genet Metab 2004, 83(1-2):6-15.
10. Bultron G., Kacena K., Pearson D., et al. The risk of Parkinson's disease in type 1 Gaucher disease. J Inherit Metab Dis 2010, 33(2):167-173.
11. Lee H.J., Khoshaghideh F., Patel S., Lee S.J. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004, 24(8):1888-1896.
12. Sidransky E., Nalls M.A., Aasly J.O., et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009, 361(17):1651-1661.
13. Kumar K.R., Ramirez A., Göbel A., et al. Glucocerebrosidase mutations in a Serbian Parkinson's disease population. Eur J Neurol 2013, 20(2):402-405.
14. Sidransky E., Lopez G. The link between the GBA gene and parkinsonism. Lancet Neurol 2012, 11(11):986-998.
15. Segarane B., et al. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 2009, 72(13):1185-1186.
16. Nalls M.A., Duran R., Lopez G., et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 2013, 70(6):727-735.
17. Zech M., Nübling G., Castrop F., et al. Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders. PLoS One 2013, 8(12):e82879.
18. Vanier M.T. Niemann-Pick disease type C review. Orphanet J Rare Dis 2010, 5(16):1-8.
19. Patterson M.C., Hendriksz C.J., Walterfang M., et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab 2012, 106(3):330-344.
20. Lyseng-Williamson K.A. Miglustat: a review of its use in Niemann-Pick disease type C. Drugs 2014, 74(1):61-74.
21. Vance J.E. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Model Mech 2012, 5(6):746-755.
22. Björnsson O.G., Sparks J.D., Sparks C.E., Gibbons G.F. Regulation of VLDL secretion in primary culture of rat hepatocytes: involvement of cAMP and cAMP-dependent protein kinases. Eur J Clin Invest 1994, 24(2):137-148.
23. Bodovitz S., Klein W.L. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 1996, 271(8):4436-4440.
24. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A 2001, 98(10):5815-5820.
25. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 1998, 95(11):6460-6464.
26. Liscum L., Ruggiero R.M., Faust J.R. The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J Cell Biol 1989, 108(5):1625-1636.
27. Jin L.W., Shie F.S., Maezawa I., Vincent I., Bird T. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol 2004, 164(3):975-985.
28. Yamazaki T., Chang T.Y., Haass C., Ihara Y. Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-Pick type C cells. J Biol Chem 2001, 276(6):4454-4460.
29. Koh C.H., Cheung N.S. Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease. Cell Signal 2006, 18(11):1844-1853.
30. Bignall J. APOE gene dose in Alzheimer's disease. Lancet 1993, 342(8868):426.
31. Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261(5123):921-923.
32. Slooter A.J., Cruts M., Kalmijn S., et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam study. Arch Neurol 1998, 55(7):964-968.
33. Fu R., Yanjanin N.M., Elrick M.J., Ware C., Lieberman A.P., Porter F.D. Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. Am J Med Genet 2012, 158A(11):2775-2780.
34. Mattsson N., Zetterberg H., Bianconi S., et al. Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C a cross-sectional study. Neurology 2011, 76(4):366-372.
35. Nixon R.A. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol Aging 2005, 26(3):373-382.
36. Auer I.A., Schmidt M.L., Lee V.M., et al. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol 1995, 90(6):547-551.
37. Yu W., Ko M., Yanagisawa K., Michikawa M. Neurodegeneration in heterozygous Niemann-Pick type C1 (NPC1) mouse: implication of heterozygous NPC1 mutations being a risk for tauopathy. J Biol Chem 2005, 280(29):27296-27302.
38. Borbon I.A., Erickson R.P. Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's. J Appl Genet 2011, 52(2):213-218.
39. Harzer K., Beck-Wödl S., Bauer P. Niemann-Pick disease type C: new aspects in a long published family - partial manifestations in heterozygotes. JIMD Rep 2014, 12:25-29.
40. Josephs K.A., Matsumoto J.Y., Lindor N.M. Heterozygous Niemann-Pick disease type C presenting with tremor. Neurology 2004, 63(11):2189-2190.
41. Kluenemann H.H., Nutt J.G., Davis M.Y., Bird T.D. Parkinsonism syndrome in heterozygotes for Niemann-Pick C1. J Neurol Sci 2013, 335(1-2):219-220.
42. Brown D.E., Thrall M.A., Walkley S.U., et al. Metabolic abnormalities in feline Niemann-Pick type C heterozygotes. J Inherit Metab Dis 1996, 19(3):319-330.
43. Wollmer M.A., Sleegers K., Ingelsson M., et al. Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics 2007, 8(3):179-188.
44. Erickson R.P., Larson-Thomé K., Weberg L., et al. Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci Lett 2008, 447(2-3):153-157.
45. Liu X., Cheng R., Verbitsky M., et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet 2011, 12:104.
46. Wimo A., Prince M. World Alzheimer report 2010. The global economic impact of dementia 21 September 2010, Alzheimer's Disease International (Adi).
47. Hort J., O'Brien J.T., Gainotti G., et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 2010, 17(10):1236-1248.
48. Chetrit E.B., Alcalay R.N., Steiner-Birmanns B., et al. Phenotype in patients with Gaucher disease and Parkinson disease. Blood Cells Mol Dis 2012, 50(3):218-221.